Improving the lives of people with neurodevelopmental disabilities

Neuren (ASX: NEU) has two drugs in clinical development for multiple serious neurological disorders that emerge in early childhood, for which currently there are no approved drug therapies

Watch video introduction to Neuren and trofinetide